NR1I2 and neoplasm: The downstream genes of PXR, such as P-GP, metabolize and eliminate antitumor drugs in tumor cells or tissues through various pathways, which can ultimately reduce the effective concentration of the drug in the tumor cells or tissues and finally induce the tumor cells to resist tumor drugs47,48.